Chemosensitization of cancer cells by the staurosporine derivative CGP 41251 in association with decreased P-glycoprotein phosphorylation

This publication has 10 references indexed in Scilit:

• A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
  Published by Elsevier ,2003
• Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells
  British Journal of Cancer, 1996
• Evidence that protein kinase C-α activation is a critical event in phorbol ester-induced multiple drug resistance in human colon cancer cells
  Biochemical Pharmacology, 1994
• The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance
  International Journal of Cancer, 1994
• Differential modulation of P-glycoprotein transport by protein kinase inhibition
  Biochemistry, 1993
• Staurosporine reduces P-glycoprotein expression and modulates multidrug resistance
  Cancer Letters, 1993
• Transfection with Protein Kinase Cα Confers Increased Multidrug Resistance to MCF-7 Cells Expressing P-Glycoprotein
  Cancer Communications, 1991
• Human Multidrug Resistant KB Cells Overexpress Protein Kinase C: Involvement in Drug Resistance
  Cancer Communications, 1989
• A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity
  International Journal of Cancer, 1989
• Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells
  FEBS Letters, 1989